Judge OKs $35M Teva Deal In Delayed Generic Inhalers Suit
A Massachusetts federal judge has approved an antitrust settlement that will see Teva Pharmaceuticals pay $35 million to resolve claims that it schemed to delay generic competition for its QVAR asthma...To view the full article, register now.
Already a subscriber? Click here to view full article